Cite

MLA Citation

    D S Ziegler et al.. “366PActivity of larotrectinib in TRK fusion cancer patients with primary central nervous system tumours.” Annals of oncology, vol. 30, n.d., p. . http://access.bl.uk/ark:/81055/vdc_100098039030.0x00003a
  
Back to record